Sublingual vaccination with sonicated Salmonella proteins and mucosal adjuvant induces mucosal and systemic immunity and protects mice from lethal enteritis

APMIS

Volumn 119, Issue 7, 2011, Pages 468-478

  Huang, Ching Feng ^a   Wu, Tzee Chung ^b,c   Wu, Chia Chao ^a   Lee, Chin Cheng ^d   Lo, Wen Tsung ^a   Hwang, Kwei Shuai ^a   Hsu, Mu Ling ^e   Peng, Ho Jen ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^e HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Adjuvant; Mucosa immunity; Salmonella; Sublingual; Vaccine

Indexed keywords

CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; SALMONELLOSIS VACCINE; SECRETORY IMMUNOGLOBULIN; SONICATED SALMONELLA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL DEGENERATION; CELL VACUOLE; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG SCREENING; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; INTERFERON PRODUCTION; INTESTINE NECROSIS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SALIVA LEVEL; SALMONELLA ENTERITIDIS; SPLEEN CELL; SURVIVAL RATE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, SUBLINGUAL; ANIMALS; BACTERIAL PROTEINS; CHOLERA TOXIN; CPG ISLANDS; ENTERITIS; IMMUNITY, ACTIVE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA VACCINES; SURVIVAL RATE;

EID: 79958141470     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02761.x     Document Type: Article

References (36)

1. Rabsch W, Tschape H, Baumler AJ. Non-typhoidal salmonellosis: emerging problems. Microbes Infect 2001;3:237-47.
2. Wang S, Duan H, Zhang W, Li JW. Analysis of bacterial foodborne disease outbreaks in China between 1994 and 2005. FEMS Immunol Med Microbiol 2007;51:8-13.
3. Kunisawa J, Kiyono H. A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense. Cell Mol Life Sci 2005;62:1308-21.
4. Mapletoft JW, Latimer L, Babiuk LA, van Drunen Littel-van den Hurk S. Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies. Clin Vaccine Immunol 2010;17:23-35.
5. Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, et al. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children. Infect Immun 2004;72:6586-8.
6. Hamid N, Jain SK. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid. Clin Vaccine Immunol 2008;15:1461-71.
7. Rask C, Fredriksson M, Lindblad M, Czerkinsky C, Holmgren J. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant. APMIS 2000;108:178-86.
8. Ikewaki J, Nishizono A, Goto T, Fujioka T, Mifune K. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol 2000;44:29-39.
9. Peng HJ, Tsai LC, Su SN, Chang ZN, Shen HD, Chao PL, et al. Comparison of different adjuvants of protein and DNA vaccination for the prophylaxis of IgE antibody formation. Vaccine 2004;22:755-61.
10. Freytag LC, Clements JD. Mucosal adjuvants. Vaccine 2005;23:1804-13.
11. Fu TJ, Abbott UR, Hatzos C. Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid - a comparative study. J Agric Food Chem 2002;50:7154-60.
12. Peng HJ, Chang ZN, Tsai LC, Su SN, Shen HD, Chang CH. Heat denaturation of egg-white proteins abrogates the induction of oral tolerance of specific Th2 immune responses in mice. Scand J Immunol 1998;48:491-6.
13. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:1021-35.
14. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004;59:1205-10.
15. Frew AJ. Sublingual immunotherapy. N Engl J Med 2008;358:2259-64.
16. Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, et al. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci USA 2008;105:1644-9.
17. Peng HJ, Chang ZN, Han SH, Won MH, Huang BT. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice. Scand J Immunol 1995;42:297-304.
18. Strindelius L, Filler M, Sjoholm I. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine 2004;22:3797-808.
19. Bergquist C, Lagergard T, Holmgren J. Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid. APMIS 1998;106:800-6.
20. Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, et al. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A. Clin Vaccine Immunol 2009;16:444-52.
21. Flach CF, Svensson N, Blomquist M, Ekman A, Raghavan S, Holmgren J. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori. Vaccine 2011;29:1235-41.
22. Raghavan S, Ostberg AK, Flach CF, Ekman A, Blomquist M, Czerkinsky C, et al. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun 2010;78:4251-60.
23. Maeda K, Yamashiro T, Minoura T, Fujioka T, Nasu M, Nishizono A. Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol 2002;46:613-20.
24. Jiang W, Baker HJ, Smith BF. Mucosal immunization with Helicobacter, CpG DNA, and cholera toxin is protective. Infect Immun 2003;71:40-6.
25. Huang CF, Wang CC, Wu TC, Chu CH, Peng HJ. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG or cholera toxin on systemic Th2 immune responses and mucosal immunity in mice. Ann Allergy Asthma Immunol 2007;99:443-52.
26. El-Malky M, Shaohong L, Kumagai T, Yabu Y, Noureldin MS, Saudy N, et al. Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice. Microbiol Immunol 2005;49:639-46.
27. Eriksson K, Fredriksson M, Nordstrom I, Holmgren J. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect Immun 2003;71:1740-7.
28. Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, Sun JB, et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 2007;25:8598-610.
29. Brandtzaeg P. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 1995;103:1-19.
30. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992;60:1786-92.
31. Strindelius L, Folkesson A, Normark S, Sjoholm I. Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice. Vaccine 2004;22:1448-56.
32. Snoeck V, Peters IR, Cox E. The IgA system: a comparison of structure and function in different species. Vet Res 2006;37:455-67.
33. Horner AA, Ronaghy A, Cheng PM, Nguyen MD, Cho HJ, Broide D, et al. Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunol 1998;190:77-82.
34. Piao HH, Tam VT, Na HS, Kim HJ, Ryu PY, Kim SY, et al. Immunologic responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice. J Microbiol 2010;48:486-95.
35. Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 1987;317:1101-4.
36. Hougen HP, Jensen ET, Klausen B. Experimental Salmonella typhimurium infections in rats. II. Active and passive immunization as protection against a lethal bacterial dose. APMIS 1990;98:30-6.